Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Elivaldogene autotemcel Infusion bulk supplier for pharma manufacturers

Elivaldogene Autotemcel Infusion Cells /kg patient Suppliers & Bulk Manufacturers

Available Forms: Intravenous infusion

Available Strengths: Cells /kg patient

Reference Brands: Skysona(US & EU)

Category: Cell & Gene Therapies

Elivaldogene autotemcel (Skysona) is a gene therapy that delivers a functional ABCD1 gene via viral vectors, halting or slowing adrenoleukodystrophy (ALD) progression. It reduces neurological decline, stabilizes cognitive function, and improves quality of life when administered early in specialized centers, offering long-term disease management.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Elivaldogene autotemcel (Skysona) is regulated in the US and EU, supported by dossiers demonstrating safety, efficacy, and manufacturing quality in compliance with GMP and MDR standards. In the US, FDA approval involved extensive clinical validation, safety assessments, and comparability data. In the EU, CE marking certifies conformity with MDR requirements, with ongoing approval processes in some member states. These gene therapies undergo validation, stability testing, and audits, supported by comprehensive documentation including safety profiles, clinical trial data, and manufacturing practices. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring regulatory compliance guarantees access to innovative treatments supporting early intervention in cerebral ALD worldwide.

Elivaldogene Autotemcel Infusion — third party manufacturing & bulk supply

Elivaldogene Autotemcel Infusion Cells /kg patient is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Elivaldogene Autotemcel Infusion is supplied as Intravenous infusion — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Elivaldogene Autotemcel Infusion listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Elivaldogene Autotemcel Infusion →
Back to Listing

Frequently Asked Questions

Elivaldogene autotemcel Infusion is listed as Intravenous infusion in Cells /kg patient. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Elivaldogene autotemcel Infusion is referenced against Skysona(US & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.

Related Products

Valoctocogene Roxaparvovec Infusion

Strength:
A single-dose gene therapy designed to increase factor VIII production in hemophilia A patients

Form: Intravenous infusion

Reference Brands: Roctavian(US & EU)

View Details
Etranacogene Dezaparvovec. Infusion

Strength:
Cells/kg patient

Form: Intravenous infusion

Reference Brands: Hemgenix (US & EU)

View Details
Voretigene Neparvovec Infusion

Strength:
cells/kg patient

Form: Subretinal injection

Reference Brands: Luxturna(US & EU)

View Details
Darleukin Injection

Strength:
A standardized dose of 120 million adipose-derived stem cells per injection

Form: Intralesional injection

Reference Brands: Alofisel(US & EU)

View Details
Lisocabtagene Maraleucel Infusion

Strength:
Approved for relapsed/refractory large B-cell lymphoma, with a standard dose of 100 million CAR T cells per infusion

Form: IV Infusion

Reference Brands: Breyanzi (US & EU)

View Details
Idecabtagene Vicleucel Infusion

Strength:
Approved for relapsed/refractory multiple myeloma, with dosing based on patient weight, delivering a personalized, targeted therapy to eliminate cancer cells

Form: IV Infusion

Reference Brands: Abecma(US & EU)

View Details
Onasemnogene Abeparvovec Injectable

Strength:
Single-dose IV infusion providing 6 x 10^13 vector genomes (vg) per patient

Form: Injectable gene therapy

Reference Brands: Zolgensma(US & EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.